Revolution Medicines (RVMD) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to -$1.61.
- Revolution Medicines' EPS (Weighted Average and Diluted) fell 7127.66% to -$1.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.18, marking a year-over-year decrease of 4153.01%. This contributed to the annual value of -$3.58 for FY2024, which is 731.69% up from last year.
- As of Q3 2025, Revolution Medicines' EPS (Weighted Average and Diluted) stood at -$1.61, which was down 7127.66% from -$1.31 recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' EPS (Weighted Average and Diluted) ranged from a high of -$0.6 in Q2 2021 and a low of -$1.61 during Q3 2025
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.92, with a median of -$0.84 in 2022.
- In the last 5 years, Revolution Medicines' EPS (Weighted Average and Diluted) surged by 1527.78% in 2022 and then crashed by 9836.07% in 2023.
- Revolution Medicines' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.72 in 2021, then grew by 15.28% to -$0.61 in 2022, then plummeted by 98.36% to -$1.21 in 2023, then rose by 4.14% to -$1.16 in 2024, then tumbled by 38.8% to -$1.61 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.61 for Q3 2025, versus -$1.31 for Q2 2025 and -$1.13 for Q1 2025.